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INTRODUCTION
Equine sarcoids are the most common skin tumors 
in horses and other equids like donkeys, mules and 
zebras (Jackson, 1936; Ragland, 1970; Lazary et al., 
1985; Nel et al., 2006). They were described for the 
first time by Jackson (1936), who considered the tu-
mors as sarcoma-like mixed (fibro-epithelial) tumors. 
Equine sarcoids are observed worldwide, indepen-
dent of breed, coat color, sex or age (Ragland, 1970; 
Tarwid et al., 1985). Nevertheless, certain breeds and 
families are more vulnerable than others (Ragland et 
al., 1966; Brostrom et al., 1988; Lazary, 1988; Ger-
ber, 1989; Marti et al., 1993) and sarcoids occur most 
commonly in young adults, between 3 and 6 years 
(Marti et al., 1993; Torrontegui and Reid, 1994).
Clinically and pathologically, sarcoids present most 
of the features of a true neoplasm. The predominant 
cell type is a malignant/transformed fibroblast. Sar-
coids generally have a high capacity for local tissue 
invasion into the dermis and subcutis but true metas-
tatic dissemination does not occur (Pascoe and Knot-
tenbelt, 1999). The clinical presentation of an equine 
sarcoid can vary a lot between different individuals 
and even within the same individual. The number of 
tumors per horse varies from one single sarcoid over 
a few to more than 100 lesions (Pascoe and Knotten-
belt, 1999). A sarcoid can remain stable for years or it 
can show a rapid and aggressive growth with infiltra-
tion of surrounding skin (Ragland, 1970; Marti et al., 
1993). The reason for these large differences in clini-
cal presentation is presently not known. The infiltra-
tive behavior together with the infectious etiology is 
responsible for the frequent recurrences after treat-
ment. Sarcoids themselves are never lethal, but fai-
lure to treat them and the functional impairment they 
cause may result in euthanasia or slaughtering. The 
economic repercussion can be great: besides the cos-
metic aspect, the normal use of the horse can be hin-
dered, especially when tumors are located at the le-
vel of the girth and bridle, distal limbs, corner of the 
mouth and eyelids. Moreover a genetic component 
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aBstract
equine sarcoids are the most common skin tumors in horses and other equids. in their pathogenesis, the 
bovine papillomavirus (BPv) plays a major role. many clinical manifestations have been described, rang-
ing from small single lesions to multiple aggressively growing masses. histopathologically, it is considered 
as a biphasic tumor with epidermal hyperplasia and subepidermal proliferation of transformed fibrob-
lasts. the diagnosis can be made clinically, histopathologically and/or by detection of BPv dna. sarcoids 
can appear on any part of the body, but they are mostly localized on the ventral abdomen, the paragenital 
region, head and limbs. sarcoids occur independent of breed, coat color, sex or age, but they develop more 
commonly in young adults and certain families and breeds are more vulnerable than others. transmission 
of BPv is supposed to happen from cattle to horse or from horse to horse, possibly via insects.
SAMENVATTING
Equine sarcoïden zijn de meest voorkomende tumoren bij paarden en andere paardachtigen. Het boviene 
papillomavirus (BPV) speelt een belangrijke rol in de pathogenese. Verschillende klinische vormen worden be-
schreven gaande van kleine enkelvoudige laesies tot multipele agressief groeiende gezwellen. Histopathologisch 
worden sarcoïden beschouwd als bifasische tumoren met epidermale hyperplasie en subepidermale proliferatie 
van getransformeerde fibroblasten. De diagnose wordt gesteld aan de hand van een klinisch onderzoek, histopa-
thologie en/of de detectie van BPV DNA. Sarcoïden kunnen op het hele lichaam voorkomen, maar meestal zijn 
ze terug te vinden onderaan de buik, in de paragenitale regio, op het hoofd en op de ledematen. Sarcoïden komen 
wereldwijd voor onafhankelijk van het ras, de haarkleur, het geslacht of de leeftijd maar ontstaan toch voorname-
lijk bij jong volwassen dieren. Bepaalde lijnen en rassen zijn eveneens meer gevoelig dan andere. De transmissie 
van BPV gebeurt vermoedelijk zowel van rund naar paard als tussen paarden onderling, eventueel via insecten.
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has a role in the development of the disease, dimi-
nishing the breeding value of affected animals (La-
zary et al., 1985; Meredith et al., 1986; Gerber et al., 
1988). Diseased horses are therefore difficult to sell 
(Gerber, 1989).
In the pathogenesis, the bovine papillomavirus (BPV) 
plays a major role. Papillomaviruses are normally 
strictly species-specific, but equine sarcoids result 
from a natural cross-species infection. Although no 
intact viral particles have been demonstrated in sar-
coids so far, DNA, RNA and proteins of the virus 
can be found (Amtmann et al., 1980; Trenfield et al., 
1985; Otten et al., 1993; Teifke et al., 1994; Nasir 
and Reid, 1999; Carr et al., 2001b). Moreover, many 
similarities can be observed between equine sarcoids 
and papillomatosis in other species: fast growth, ten-
dency for multiplicity and spreading by contact over 
different parts of the body (Jackson, 1936). Epizoo-
tics have been described in closed herds of horses and 
zebras, pointing to an infectious agent (Ragland et 
al., 1966; Nel et al., 2006).
CLINICAL PRESENTATION OF EQUINE SAR-
COIDS
clinical types
Many clinical manifestations of equine sarcoids 
are known. They can be single or multiple, small to 
very large, stable or aggressively growing. At cross-
section sarcoids appear as dermal thickening with 
a pale yellow color and a firm texture due to fibro-
blastic proliferation and a small number of capilla-
ries within the tumor (Foy et al., 2002). The epider-
mis varies from thick, rough and hyperkeratotic to 
thinned or ulcerated. A classification based on mor-
phological features has been proposed by Pascoe and 
Knottenbelt (1999) and will be followed throughout 
this paper.
Verrucous sarcoids (Figure 1) have a typical wart- 
like appearance with a rough, thickened, scabby sur-
face above the fibroblastic part of the tumor (Knotten-
belt et al., 1995). They can appear as small exophytic 
growing masses or as flat, often extended, scaly are-
as of skin with multiple smaller wart-like lesions on 
the surface. Common differential diagnoses for this 
sarcoid type are warts (induced by equine papilloma-
virus), aural plaque, chronic sweet itch and chronic 
blistering (Pascoe and Knottenbelt, 1999).
Nodular sarcoids (Figure 2) are subcutaneous, 
easily moveable nodules, often but not always sphe-
rical, covered by intact, apparently normal skin (Foy 
et al., 2002). In some cases, however, the overlying 
skin can be thinner, shiny and adherent to the tumor 
(Knottenbelt et al., 1995). Differential diagnoses in-
clude eosinophilic granuloma, melanoma and other 
nodular diseases (Knottenbelt et al., 1995). 
Occult sarcoids (Figure 3) are flat circular to oval 
areas characterized by alopecia and a roughened or 
scaly appearance (Knottenbelt et al., 1995). Some-
times small cutaneous nodules can be observed (Pas-
coe and Knottenbelt, 1999). In some cases, occult 
sarcoids can be very subtle, displaying no more than 
a slightly thickened skin with a thin hair coat and 
slight changes in pigmentation. This relatively be-
nign type can evolve rapidly towards a more aggres-
sive type, either spontaneously or following injury 
such as biopsy or an erroneous treatment. Common 
differential diagnoses are dermatophytosis, chronic 
skin rubbing, alopecia areata and vitiligo (Knotten-
belt et al., 1995).
Fibroblastic sarcoids (Figure 4) are large fibrous 
masses with an ulcerated surface. This is the most ag-
gressive sarcoid type and can evolve from any other 
type after accidental or iatrogenic manipulation, in-
cluding biopsy (Knottenbelt et al., 1995; Foy et al., 
2002). In these cases it is observed that the original 
tumor starts to grow very quickly and begins to ul-
cerate. Skin wounds, especially at the distal limbs, 
are also at risk for development of fibroblastic sar-
coids. Both dehiscence of the suture line after surgery 
without an apparent reason as well as the presence of 
a slow healing hypergranulating wound can be sug-
gestive of sarcoid development (Pascoe and Knotten-
belt, 1999). Fibroblastic sarcoids are liable to trau-
ma, haemorrhage and local infection with bacteria 
or maggots. Fibroblastic sarcoids can be sessile with 
an invasive character or pedunculated with a small 
base. Differential diagnoses are exuberant granula-
tion tissue, botryomycosis, squamous cell carcinoma 
and habronemiasis in warmer climates (Knottenbelt 
et al., 1995).
Mixed sarcoids (Figure 5) are a combination of 
two or more of the above mentioned types. They can 
represent a progressive or transient state between the 
verrucous/occult types and the fibroblastic/nodular 
types (Pascoe and Knottenbelt, 1999).
Malevolent sarcoids are very rare and have been 
described only by one group (Knottenbelt et al., 
1995). These tumors infiltrate in lymphatic vessels 
resulting in multiple nodular or fibroblastic masses 
along these vessels. Local lymph nodes might also be 
involved. This type of sarcoid usually evolves from 
any of the other types following repeated injury, al-
though spontaneous transformation is also possible.
In our clinic, sarcoids infiltrating the underlying 
muscles have occasionally been observed. These sar-
coids can arise spontaneously or following failure of 
treatment resulting in deterioration of the tumor. 
This classification into different types is also re-
flecting the clinical behavior of the tumors: occult ty-
pes are the most stable tumors, nodular and verrucous 
sarcoids display a moderate growth, fibroblastic sar-
coids are often fast growing and malevolent and in-
filtrating sarcoids, although rarely seen, are the most 
aggressive sarcoid types.
HISTOPATHOLOGICAL PROPERTIES
Jackson (1936), who described the equine sarcoid 
for the first time, considered it as a biphasic tumor 
with an epidermal and dermal component. Typical 
changes are subepidermal proliferation of spindle-
shaped to fusiform fibroblasts showing hyperchro-
masia with a moderate to high cell density (Tarwid et 
al., 1985; Goodrich et al., 1998). These immature fi-
broblasts show a higher density in the superficial part 
of the tumor compared to the deeper layers (Martens 
et al., 2000). The fibroblasts are fusiform to spind-
le-shaped, forming whorls, interlacing bundles and 
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haphazard arrays with one another (Goodrich et al., 
1998). At the dermo-epidermal junction fibroblasts 
are oriented perpendicular to the basement membra-
ne, which is known as a picket-fence pattern (Rag-
land, 1970; Tarwid et al., 1985; Scott and Miller, 
2003; Pulley and Stannard, 1990; Marti et al., 1993). 
The mitotic rate is invariably low (Goodrich et al., 
1998; Martens et al., 2000). The amount of colla-
gen varies considerably between tumors  (Goodrich 
et al., 1998). In between the fibroblasts of the deeper 
layers of the dermis, large polygonal cells with large 
bas ophilic nuclei can be found. These are infiltrating 
dendritic cells that have an antigen presenting func-
tion suggesting an immune mediated defence against 
virus infected cells (von Tscharner et al., 1996; Le-
page et al., 1998). Sometimes small epithelial inclu-
sion cysts are found (Ragland, 1970; Tarwid et al., 
1985; Pulley and Stannard, 1990). In the most typical 
cases, pseudoepitheliomatous hyperplasia and hyper-
keratosis are observed. There is marked formation 
of rete pegs, which are broad invaginations (up to 
more than 20 cells) of epidermal cells into the dermis 
(Goodrich et al., 1998). However, in less typical sar-
coids the epidermal component can be normal, atro-
phic or even absent (Marti et al., 1993; Lepage et al., 
1998; Martens et al., 2000). In situ hybridization for 
BPV DNA of tissue sections from sarcoids reveals 
viral DNA in the dermal layer within the fibroblasts 
but not within the epithelial cells (Lory et al., 1993; 
Teifke et al., 1994; von Tscharner et al., 1996). Epi-
thelial changes seen in sarcoids are likely the result of 
growth-promoting factors expressed by the neoplas-
tic fibroblasts that stimulate proliferation of surroun-
ding epithelial cells (Carr et al., 2001a). 
The histological properties seem to be mainly de-
pendent of the clinical type (Martens et al., 2000). 
Most of the verrucous and mixed sarcoids display 
the histological features as described above (Figu-
re 6). In verrucous sarcoids, the epithelial compo-
nent is much more important than the dermal, some-
times only lying as a small band of active fibroblasts 
figure 1. verrucous sarcoid on the right mandible. figure 2. nodular sarcoid on the upper eyelid.
figure 3. Occult sarcoids in the paragenital region of a 
mare (ventral abdomen and medial side of the thigh).
figure 4. fibroblastic sarcoid on the dorsolateral as-
pect of the metacarpus.
Figure 5. Mixed sarcoid (verrucous – fibroblastic) on 
the upper eyelid.
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against the epidermis (Pulley and Stannard, 1990). In 
the fibroblastic type there is always partial or total 
ulceration of the epidermis with infiltration of poly-
morphonuclear cells (Martens et al., 2000). The epi-
dermis just next to the ulcerative lesions is more or 
less hyperplastic. In nodular sarcoids the epidermis 
is often thinned (Martens et al., 2000). If rete pegs 
are present, they are short. If the dermal proliferati-
on is not making contact with the epidermis, the lat-
ter is normal. In occult sarcoids (Figure 7) the epi-
dermis is usually normal or only displaying slight 
changes. The only typical aspect of this sarcoid type 
is the increased density of subepidermal fibroblasts 
infiltrating between a reduced number of hair folli-
cles and sweat glands (Martens et al., 2000). They do 
not show a typical morphology or specific whorling 
distribution pattern. The density of dermal fibroblasts 
is also lower compared to the other types of sarcoids. 
The only common property for all types of sarcoids 
is the increased density of dermal fibroblasts com-
pared to normal skin (Martens et al., 2000). Nodu-
lar sarcoids can mimic schwannomas although their 
clinical appearance and the presence of BPV demon-
strate the sarcoid origin of the tumor (Vanheerden, in 
preparation).
DIAGNOSIS
Diagnosis can be made in three ways: clinical exa - 
mination, histopathology and detection of BPV DNA. 
A thorough clinical examination combined with a fo-
cused anamnesis (duration of problems, localizati-
on of lesions, age, breed, evolution, multiplicity of 
lesions …) should be sufficient in the majority of ca-
ses. Lack of clinical experience or atypical tumor 
characteristics may cause confusion and necessitate 
lab-assisted diagnosis. Histopathological examinati-
on is often diagnostic, but it should be remarked that 
taking a biopsy, in particular of small stable lesions, 
may induce rapid growth and ulceration. If a non-ex-
cisional biopsy must be performed, sites with in the 
mass must be carefully chosen to minimize the con-
founding factors of surrounding inflammation and 
granulation and to include intact epidermis (Good-
rich et al., 1998). Possible deterioration of the sarcoid 
following biopsy is the reason why taking a biopsy 
of verrucous, occult and small nodular lesions is con-
tra-indicated, even if making a definitive diagnosis 
is not possible in such cases (Pascoe and Knotten-
belt, 1999). Another possibility is to perform a full 
surgical excision as if the lesion was a sarcoid, in-
cluding excision of wide margins of normal skin and 
non-touch approach, followed by histological confir-
mation afterwards. This allows the pathologist to ob-
serve the range of morphological characteristics of 
the tumor allowing a correct diagnosis (Goodrich et 
al., 1998).
A more recent approach in diagnosing equine sar-
coids is the detection of BPV DNA in lesions by 
means of polymerase chain reaction (PCR). This can 
be performed on histopathological samples of tissue 
suspected of equine sarcoid but not displaying the ty-
pical histological features (Angelos et al., 1991). A 
new approach is the detection of BPV DNA by means 
of PCR in the limited amount of material obtained by 
swabbing or scraping the lesions. This technique is 
especially valuable for the diagnosis of equine sar-
coid tissue in non-healing wounds and in case of re-
currences after former surgery (Martens et al., 2001). 
PCR detection of BPV DNA has many advantages: 
it is not invasive, sampling is easy and the trauma to 
the tumor is minimal. Disadvantages are the unsuita-
bility for diagnosing occult sarcoids, the lower sensi-
tivity compared to clinical diagnosis and the low spe-
cificity due to high prevalence of BPV DNA in the 
normal skin of horses (Martens et al., 2001; Bogaert 
et al., 2007a). 
EPIDEMIOLOGICAL FACTORS
 Prevalence
The equine sarcoid is the most common tumor in 
horses, donkeys, mules and zebras. Depending on the 
study, they represent 12 to 67 % of all equine tumors 
and 70 % of all skin tumors in horses (Jackson, 1936; 
figure 6. histological view of a verrucous sarcoid. note 
the irregular hyperplasia of the epidermis, that forms 
deep rete ridges in the superficial dermis. The dermis 
is replaced by a highly cellular mass, arranged in short 
interlacing and palisading bundles of small moderately 
pleiomorphic spindle cells surrounded by a basophilic 
matrix (bar = 250 µm).
figure 7. histological view of an occult sarcoid. Only 
an increased density of subepidermal fibroblasts can be 
seen together with diffuse orthokeratotic hyperkerato-
sis of the overlying epidermis (bar = 250 µm).
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Ragland, 1970; Miller and Campbell, 1982; Teifke et 
al., 1994; Lepage et al., 1998). A prevalence of 0.6 to 
2 % in clinical populations has been reported (Rag-
land, 1970; Mohammed et al., 1992; Goodrich et al., 
1998). In our clinic, 2.2 % of the patients are admit-
ted for treatment of equine sarcoids. This percenta-
ge is biased, since it can be higher than the true pre-
valence because veterinary referral hospitals can be 
specialized in sarcoid treatment and thus have a high 
case load. On the other hand, not all horses with sar-
coids are referred to the clinic: small tumors are often 
treated at home by local practitioners or are left un-
treated. Recent studies conducted on three-year-old 
horses presented for field tests in Switzerland sho-
wed a prevalence of 12 % in the Swiss Warmblood 
Horse and the Freiberger (Mele et al., 2007; Studer 
et al., 2007), which might be a more accurate estima-
tion of the true population prevalence. In populations 
of Cape mountain zebras in South Africa the preva-
lence of equine sarcoids mounted up to 53 %, but this 
high prevalence could be influenced by a high degree 
of inbreeding (Zimmerman, 2004; Nel et al., 2006).
LOCALIZATION OF TUMORS
Sarcoids can appear on any part of the body, but 
they are mostly localized on the ventral abdomen, the 
paragenital region, head and limbs (Jackson, 1936; 
Pulley and Stannard, 1990; Torrontegui and Reid, 
1994; Goodrich et al., 1998; Piscopo, 1999; Bogaert 
et al., 2007b). On the head, most tumors develop at 
the eyelids, ears and commissure of the lips (Foy et 
al., 2002). Sarcoids are least common on the dorsum 
of the trunk (Knottenbelt et al., 1995). In northern re-
gions, lesions occur predominantly on the head and 
abdomen while in warmer climates the limbs are more 
often involved (Marti et al., 1993). Apart from these 
predilection sites, sarcoids can develop at any site in 
injured skin (Torrontegui and Reid, 1994; Foy et al., 
2002). The location of sarcoids has a significant rela-
tionship to their size: sarcoids on the head are most-
ly smaller whereas sarcoids on the limbs are larger 
when compared to all other sites (Brostrom, 1995). 
Sarcoids can appear singly or in clusters (Brostrom, 
1995; Goodrich et al., 1998). Horses with multiple 
lesions tend to have larger-sized tumors compared to 
horses with a single sarcoid (Brostrom, 1995).
RISK FACTORS
age 
In contrast to most tumors observed in man and 
animals, the equine sarcoid predominantly develops 
in young adults. The majority of affected horses 
are younger than 6 years, with a peak incidence be-
tween 3 and 6 years (Miller and Campbell, 1982; 
Scott and Miller, 2003; Marti et al., 1993; Torronte-
gui and Reid, 1994; Brostrom, 1995; Piscopo, 1999; 
Foy et al., 2002). The mean age of sarcoid develop-
ment is 3.5 to 4 years (Brostrom, 1995; Studer et al., 
2007). Nevertheless, also younger and older horses 
can develop sarcoids. According to Mohammed et al. 
(1992) a gradual increase in incidence is observed up 
to the age of 15 years, followed by a decreasing in-
cidence. A study on a large group of donkeys revea-
led that mainly males between 0.5 and 3 years were 
at high risk (Reid and Gettinby, 1996). An obvious 
reason for this age distribution has not been demon-
strated yet, but possibly older horses acquire a cer-
tain level of immunity which results in spontaneous 
regression of existing tumors and prevention of new 
tumor development. Another hypothesis is that gene-
tically susceptible animals develop tumors early in 
life (Torrontegui and Reid, 1994). 
sex
Most authors do not assume that there is a gen-
der predisposition for sarcoid development (Ragland, 
1970; Miller and Campbell, 1982; Pulley and Stan-
nard, 1990; Torrontegui and Reid, 1994). However, 
others claim that geldings are more susceptible than 
stallions and mares. Mohammed et al. (1992) ob-
served that the risk for geldings to develop sarcoids 
was twice as high compared to stallions and mares. 
In donkeys, a predisposition in males was observed 
(Reid et al., 1994; Reid and Gettinby, 1996). A possi-
ble explanation is that in castrated males a wound is 
created which is a possible entrance for BPV (Reid et 
al., 1994). On the other hand, in spite of the frequent 
localization of sarcoids in the paragenital region, 
the castration wound itself is only seldom affected. 
Another hypothesis is that female animals have pro-
tective factors, rather than a predisposition in males 
(Reid and Mohammed, 1997).
Breed
 
There is clear breed predisposition for the develop-
ment of equine sarcoids (Marti et al., 1993). In North-
America, Quarter Horses are twice as likely to deve-
lop sarcoids compared to Thoroughbreds (Angelos et 
al., 1988). Also Appaloosas and Arabian Horses are 
more frequently affected than Thoroughbreds (Ange-
los et al., 1988; Mohammed et al., 1992). Standard-
breds on the other hand are rather resistant (Mere-
dith et al., 1986; Mohammed et al., 1992; Brostrom, 
1995). A possible explanation is that Quarter Horses 
and Appaloosas are often used on large cattle farms 
which results in a higher risk to get in contact with 
BPV (Mohammed et al., 1992). Moreover they of-
ten work on rough surfaces resulting in frequent in-
jury to the limbs and the possibility for sarcoid deve-
lopment in these wounds (Brostrom, 1995). Another 
more plausible explanation for breed predisposition 
can be found in the different genetic background of 
these breeds (Lazary et al., 1985; Meredith et al., 
1986). 
genetic background
The most important genes known to play a role in 
sarcoid development are those of the major histocom-
patibility complex (MHC), but also other genes are 
involved. The genes of the MHC code for proteins in-
volved in the immune response and for protein com-
ponents of the complement system (Piscopo, 1999). 
In horses these proteins are called equine leucocyte 
antigens (ELA). Three major classes of MHC genes 
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exist (Lazary et al., 1994): class I genes code for gly-
coproteins on the cell wall of most nucleated cells. 
They have a role in recognition and killing of virus 
infected cells. Seventeen internationally accepted al-
leles (A1-10, A14-15, A19, W16-18, W20) and 5 re-
gional variants (Be22, Be24-26, Be108) are distin-
guished serologically in the horse. Class II proteins 
are expressed on the cell surface of antigen presen-
ting cells. Within this class the DQB gene is highly 
polymorphic. In the horse 3 internationally accepted 
alleles (W13, W22-23) and 2 local variants (BeVI-
II, Be200) can be determined serologically (Lazary, 
1988; Hesford et al., 1989). To date, the complete se-
quence coding the ELA-DQB gene is known (Sza-
lai et al., 1994) and more than 23 DQB sequences 
have been reported in domestic horses (Gyllensten et 
al., 1990; Szalai et al., 1993; Horin and Matiasovic, 
2002), but not all reported sequences can be assig-
ned to a serological specificity (Villegas-Castagnasso 
et al., 2003). Recent evidence suggests the presen-
ce of at least two copies of the horse DQB gene (Ho-
rin and Matiasovic, 2002; Villegas-Castagnasso et 
al., 2003), one of them probably being a pseudogene. 
This genome organisation hampers an easy classifi-
cation of DQB variants with modern molecular tech-
niques such as PCR-RFLP. Class III genes encode 
several proteins involved in the complement system, 
but these are not associated with predisposition for 
sarcoids.
In most breeds such as the Swiss Warmblood, the 
Irish Warmblood, the Swedish Halfbred and the Selle 
Français, the presence of equine sarcoids is strongly 
correlated with ELA W13 (Meredith et al., 1986; 
Brostrom et al., 1988; Gerber et al., 1988; Lazary et 
al., 1994; Brostrom, 1995). A higher percentage of 
recurrences is also observed in the presence of this 
allele (Brostrom, 1995). Standardbreds lack W13, 
which might be a reason for the low prevalence of 
equine sarcoids in this breed (Meredith et al., 1986). 
In the Freiberger, a Swiss draft horse, W13 is also 
lacking, but a higher sensitivity for sarcoid develop-
ment is correlated with Be108, a local variant (Lazary 
et al., 1994). In the Selle Français, A3 is correlated 
with a higher prevalence of sarcoids, but this could 
be due to linkage disequilibrium with W13 (Lazary 
et al., 1994). Indeed, ELA A3W13 is frequently seen 
as one of the paternal haplotypes in families where 
equine sarcoids are more commonly observed than 
in others (Brostrom et al., 1988; Gerber et al., 1988). 
A5 would be correlated with early onset of sarcoids 
(Brostrom, 1995).  The association of equine sarcoids 
with certain antigens is however not absolute. A lar-
ge proportion of horses are carriers of W13, but only 
a small part of them will develop sarcoids (Goodrich 
et al., 1998). On the other hand, also horses lacking 
W13 may be affected by sarcoids. Maybe these alle-
les are only markers of other susceptibility genes in 
linkage disequilibrium with the MHC, with a more 
direct influence on the pathogenesis (Brostrom et al., 
1988; Gerber et al., 1988; Lazary et al., 1994). Still it 
seems plausible that genes coding for proteins regu-
lating the immune system can also influence the sus-
ceptibility for certain diseases (Piscopo, 1999). In-
deed, in virus-induced tumors the virus-infected cells 
express new cell wall antigens, both virus specific 
and virus induced non-viral products. These foreign 
antigens should normally be recognized by the im-
mune system resulting in destruction of tumor cells. 
If a failure occurs in the immune system, recognition 
and destruction of tumoral cells may also fail. In man 
and rabbits, a linkage between papillomavirus indu-
ced cancer and MHC alleles has also been observed 
(Wank and Thomssen, 1991; Han et al., 1992).
In Arabian Horses a significant correlation exists 
between presence of equine sarcoids and heterozy-
gosity for the defective DNA protein kinase catalytic 
subunit (DNA-PKcs) allele, which is in homozygous 
condition responsible for severe combined immuno-
deficiency. In a population of Arabian Horses, 8.7 % 
of the animals were carriers of the defective DNA-
PKcs allele, compared to 18.6 % of the equine sar-
coid affected animals (Ding et al., 2002).
TRANSMISSION
The way horses get infected with BPV is not yet 
clarified. Possible transmission routes are direct con-
tact with cattle (Jackson, 1936), indirect transmission 
from cattle to horses (e.g. housing of horses in cattle 
stables, transmission by caretakers of the animals) 
and transmission from horses with sarcoids to other 
horses (direct or indirect via caretaker, tack, grooming 
equipment, common rubbing posts) (Bogaert et al., 
2005; Bogaert et al., 2007a). In donkeys it is known 
that animals having close contact with affected ani-
mals are at higher risk for development of sarcoids 
(Reid et al., 1994). Epidemiological data, multipli-
city of tumors on one horse, spontaneous develop-
ment of sarcoids on intact skin and absence of con-
tact with cattle or affected horses suggest that flies or 
other insects may play an important role as mechani-
cal vector in BPV infection of the horse (Voss, 1969; 
Reid et al., 1994; Torrontegui and Reid, 1994; Knot-
tenbelt et al., 1995; Pascoe and Knottenbelt, 1999). 
Recently, Kemp-Symonds and Kirk (2007) have de-
monstrated the presence of BPV-1 and -2 in Musca 
autumnalis face flies infesting sarcoid affected hor-
ses. Moreover, it is observed that in one specific re-
gion identical variants of BPV are seen both in hor-
ses and in cattle, also pointing into the direction of a 
flyborn transmission (Otten et al., 1993). In case of 
a skin wound, BPV coincidentally present in the en-
vironment of the horse can immediately come into 
contact with the subepidermal fibroblasts via insects 
(Reid et al., 1994; Torrontegui and Reid, 1994; Knot-
tenbelt et al., 1995; Pascoe and Knottenbelt, 1999). 
Furthermore, cell growth is already stimulated as part 
of wound regeneration. This can eventually lead to 
malignant transformation of these cells (Phelps et al., 
1999; Foy et al., 2002). 
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Onderzoek naar equine sarcoïd
Op de Vakgroep Heelkunde en Anesthesie van de Huisdieren van de Faculteit Diergeneeskunde te Merelbeke 
loopt momenteel een onderzoek naar de transmissie van het boviene papillomavirus. Hiervoor zijn we op zoek 
naar proefpaarden met equine sarcoïden, evenals naar paarden die vroeger reeds behandeld werden voor sarcoï-
den maar nu sarcoïd-vrij zijn. Deze paarden zullen gebruikt worden om de exacte manier van transmissie te ont-
rafelen, uitgaande van viraal materiaal afkomstig van zowel runderen als van paarden. Opgelet: deze paarden zul-
len worden overgekocht door de vakgroep en kunnen dus niet in het bezit blijven van de eigenaar! Indien u in uw 
cliënteel dergelijke dieren hebt die anders toch moeten geëuthanaseerd of geslacht worden, kunt u ons steeds con-
tacteren voor overname van deze dieren.
Contact: Pieter Depoorter (pieter.depoorter@UGent.be), Lies Bogaert (lies.bogaert@UGent.be)  
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